Sat0123 Risk for Tuberculosis During Treatment With Biological Therapy: Is It Time for Reviewing Screening Protocol? – Results From Brazilian Registry of Biological Therapies in Rheumatic Diseases (Biobadabrasil)

Medeiros, Ana; Valim, V.; Pinheiro, M.; Macieira, C.; Duarte, A.; Stadler, B.; Ranza, R.; Miranda, J.; Brenol, C.; Castro, G.; Fernandes, V.; Titton, D.; Sauma, F.; Pereira, I.; Carvalho, H.; Hayata, A.; Louzada, P.; Ranzolin, A.; Studart, S.; Castelar, G.; Kakehasi, A.; Silveira, I.; Resende, H.; Rocha, L.; Gazzeta, M.; Carvalho, L.; Schowalski, S.; Feldman, D.; Laurindo, I.; Provenza, J.; Bertolo, M.; Botelho, R.; Bredemeier, Markus; Bianchi, W.; Acayaba, R.; Amaral, J.

Published in

SATURDAY, 15 JUNE 2019, 2019

DOI: 10.1136/annrheumdis-2019-eular.4624

Tools

Export citation

Search in Google Scholar

Sat0123 Risk for Tuberculosis During Treatment With Biological Therapy: Is It Time for Reviewing Screening Protocol? – Results From Brazilian Registry of Biological Therapies in Rheumatic Diseases (Biobadabrasil)

Journal article published in 2019 by Ana Medeiros, V. Valim, M. Pinheiro, C. Macieira, A. Duarte, B. Stadler, R. Ranza, J. Miranda, C. Brenol, G. Castro, V. Fernandes, D. Titton, F. Sauma, I. Pereira, H. Carvalho and other authors.

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Preprint: policy unknown

Upload

Postprint: policy unknown

Upload

Published version: policy unknown

Upload

Published in

Links

Tools

Sat0123 Risk for Tuberculosis During Treatment With Biological Therapy: Is It Time for Reviewing Screening Protocol? – Results From Brazilian Registry of Biological Therapies in Rheumatic Diseases (Biobadabrasil)